Metsera (MTSR) says in a Delaware court filing that it will accept superior bids until closing and states that Pfizer (PFE) drops its demand that Metsera denounce the Novo Nordisk (NVO) bid, according to Bloomberg.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MTSR:
- Metsera falls after FTC raises filing concerns over Novo bid
- FTC says Novo bid for Metsera raises filing concerns, Bloomberg reports
- Metsera drops 5% to $69.55 after Bloomberg report of FTC filing concerns
- M&A News: Novo Nordisk Stock (NVO) Slides after Increasing Its Metsera Offer to $10B
- Midday Fly By: Palantir reports Q3 beat, Starbucks forms China JV